BioCentury | Jun 11, 2001
Company News

BruCells S.A./N.V., Genzyme Molecular deal

...program at BruCells on the technology, which will be used to develop patient-specific cancer vaccines. BruCells S.A./N.V...
BioCentury | Jun 4, 2001
Company News

GZMO, BruCells in licensing deal

...fusion of dendritic and tumor cells. GZMO also will sponsor a two-year research program at BruCells...
Items per page:
1 - 2 of 2
BioCentury | Jun 11, 2001
Company News

BruCells S.A./N.V., Genzyme Molecular deal

...program at BruCells on the technology, which will be used to develop patient-specific cancer vaccines. BruCells S.A./N.V...
BioCentury | Jun 4, 2001
Company News

GZMO, BruCells in licensing deal

...fusion of dendritic and tumor cells. GZMO also will sponsor a two-year research program at BruCells...
Items per page:
1 - 2 of 2